Reference Source

Council De L'Europe · 66-66 · FRANCE

For Council De L'Europe · 66-66 · FRANCE, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is FRANCE; product is Kanamycin Monosulphate | Vancomycin | Famotidine | Felodipine | Prednisolone; product code is 56 D - S 31 Kanamycin Sulfate (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf | 56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf | 60 S - S 22 Famotidine (Antacid), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 32 Felodipine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 64 L - S 50 Prednisolone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is Ave De L'Europe , BP 431 , Strasbourg Cedex, FRANCE, verified against its source on 2026-09-16.

Firm
Council De L'Europe verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
FRANCE verified
Address
Ave De L'Europe , BP 431 , Strasbourg Cedex, FRANCE verified
Date published
09/30/2009 verified
Product code
56 D - S 31 Kanamycin Sulfate (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf | 56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf | 60 S - S 22 Famotidine (Antacid), Active Pharm Ingred/Chems for Further Manuf | 62 O - S 32 Felodipine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf | 64 L - S 50 Prednisolone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf each item verified
Product
Kanamycin Monosulphate | Vancomycin | Famotidine | Felodipine | Prednisolone each item verified
FDA notes
11/2/2000 | 11/2/2000 | 11/2/2000 | 11/2/2000 each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Council De L'Europe Date Published : 09/30/2009 Ave De L'Europe , BP 431 , Strasbourg Cedex, FRANCE 56 D - S 31 Kanamycin Sulfate (Aminoglycosides), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Kanamycin Monosulphate Notes: 11/2/2000 56 K - S 85 Vancomycin Hydrochloride, Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Vancomycin Notes: 11/2/2000 60 S - S 22 Famotidine (Antacid), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Famotidine Notes: 11/2/2000 62 O - S 32 Felodipine (Anti-Hypertensive - Part II), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Felodipine 64 L - S 50 Prednisolone (Glucocorticoid), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Prednisolone Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.